351 related articles for article (PubMed ID: 27097894)
1. The podocyte as a direct target for treatment of glomerular disease?
Mallipattu SK; He JC
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F46-51. PubMed ID: 27097894
[TBL] [Abstract][Full Text] [Related]
2. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
3. Glomerular pathology and the progression of chronic kidney disease.
Lemley KV
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1385-8. PubMed ID: 27122538
[TBL] [Abstract][Full Text] [Related]
4. The beneficial role of retinoids in glomerular disease.
Mallipattu SK; He JC
Front Med (Lausanne); 2015; 2():16. PubMed ID: 25853135
[TBL] [Abstract][Full Text] [Related]
5. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.
Jiang H; Shen Z; Zhuang J; Lu C; Qu Y; Xu C; Yang S; Tian X
Front Immunol; 2023; 14():1335936. PubMed ID: 38288116
[TBL] [Abstract][Full Text] [Related]
6. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
7. Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
Manabe S; Nitta K; Nagata M
Contrib Nephrol; 2018; 195():131-142. PubMed ID: 29734158
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
9. The role of podocytes in glomerular pathobiology.
Asanuma K; Mundel P
Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
[TBL] [Abstract][Full Text] [Related]
10. [Podocyte injury and glomerular sclerosis].
Matsusaka T
Nihon Rinsho; 2004 Oct; 62(10):1805-10. PubMed ID: 15500122
[TBL] [Abstract][Full Text] [Related]
11. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
12. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
13. How immunosuppressive drugs may directly target podocytes in glomerular diseases.
Salvadori M; Tsalouchos A
Pediatr Nephrol; 2022 Jul; 37(7):1431-1441. PubMed ID: 34244853
[TBL] [Abstract][Full Text] [Related]
14. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
[TBL] [Abstract][Full Text] [Related]
15. Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.
Gu L; Dai Y; Xu J; Mallipattu S; Kaufman L; Klotman PE; He JC; Chuang PY
AIDS; 2013 Apr; 27(7):1091-8. PubMed ID: 23343908
[TBL] [Abstract][Full Text] [Related]
16. Urinary and glomerular podocytes in patients with chronic kidney diseases.
Hanamura K; Tojo A; Fujita T
Clin Exp Nephrol; 2014 Feb; 18(1):95-103. PubMed ID: 23670304
[TBL] [Abstract][Full Text] [Related]
17. BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function.
Endlich N; Lange T; Kuhn J; Klemm P; Kotb AM; Siegerist F; Kindt F; Lindenmeyer MT; Cohen CD; Kuss AW; Nath N; Rettig R; Lendeckel U; Zimmermann U; Amann K; Stracke S; Endlich K
J Cell Mol Med; 2018 Nov; 22(11):5265-5277. PubMed ID: 30133147
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney.
Srivastava T; Alon US; Cudmore PA; Tarakji B; Kats A; Garola RE; Duncan RS; McCarthy ET; Sharma R; Johnson ML; Bonewald LF; El-Meanawy A; Savin VJ; Sharma M
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1323-33. PubMed ID: 25234310
[TBL] [Abstract][Full Text] [Related]
19. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
[TBL] [Abstract][Full Text] [Related]
20. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy.
Kodama F; Asanuma K; Takagi M; Hidaka T; Asanuma E; Fukuda H; Seki T; Takeda Y; Hosoe-Nagai Y; Asao R; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2013 Jul; 28(7):1762-72. PubMed ID: 23143340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
